Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NSE India Stock Exchange  >  Sun Pharmaceutical Industries Ltd.    SUNPHARMA   INE044A01036

SUN PHARMACEUTICAL INDUSTRIES LTD.

(SUNPHARMA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nse India Stock Exchange
01/18/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
581.45(c) 596.55(c) 594.7(c) 582.9(c) 575.2(c) Last
7 414 570 5 500 391 5 182 972 4 546 393 5 591 688 Volume
-3.78% +2.60% -0.31% -1.98% -1.32% Change
More quotes
Financials
Sales 2021 343 B 4 697 M 4 697 M
Net income 2021 32 879 M 451 M 451 M
Net cash position 2021 54 351 M 745 M 745 M
P/E ratio 2021 35,1x
Yield 2021 0,50%
Sales 2022 378 B 5 176 M 5 176 M
Net income 2022 57 550 M 789 M 789 M
Net cash position 2022 90 702 M 1 243 M 1 243 M
P/E ratio 2022 23,9x
Yield 2022 0,61%
Capitalization 1 380 B 18 909 M 18 911 M
EV / Sales 2021 3,87x
EV / Sales 2022 3,41x
Nbr of Employees 36 000
Free-Float 44,1%
More Financials
Company
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2020, the group had 43 production plants... 
More about the company
Notations Surperformance© of Sun Pharmaceutical Industries Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about SUN PHARMACEUTICAL INDUSTRIES LTD.
01/07LUPIN : Gets US FDA Approval for Bacterial Infection Treatment Drug
MT
01/05SUN PHARMACEUTICAL INDUSTRIES : Pharma to announce third quarter results on Janu..
AQ
01/05SUN PHARMACEUTICAL INDUSTRIES : Pharma announces initiation of Phase 2 Clinical ..
AQ
2020Sensex, Nifty end at all-time high as Reliance, TCS gain
RE
2020Indian shares end at all-time high as Reliance, TCS gain
RE
2020SUN PHARMACEUTICAL INDUSTRIES : Pharma reports Q2FY21 results
AQ
2020Indian Indices Close Higher on Wednesday; State Bank of India's Fiscal Q2 Pro..
MT
2020Sun Pharma Records Sharp Jump in September Quarter Net Profit
MT
2020Indian Indices End Deep in Green on Tuesday; Sun Pharmaceutical Rises 4%
MT
2020Nifty, Sensex end higher as financials rally, factory data firms
RE
2020SUN PHARMACEUTICAL INDUSTRIES LTD. : Half-year results
CO
2020SUN PHARMACEUTICAL INDUSTRIES : Pharma Announces 5-Year Sustained Efficacy and S..
AQ
2020SUN PHARMACEUTICAL INDUSTRIES LTD. : half-yearly earnings release
2020SUN PHARMACEUTICAL INDUSTRIES : Pharma announces the launch of ILUMYA for treatm..
AQ
2020SUN PHARMACEUTICAL INDUSTRIES, INC. : Issues Voluntary Nationwide Recall of RIOM..
BU
More news
News in other languages on SUN PHARMACEUTICAL INDUSTRIES LTD.
2020SUN PHARMACEUTICAL INDUSTRIES LTD. : Veröffentlichung des Halbjahresergebnisses
2020SUN PHARMACEUTICAL INDUSTRIES LTD. : publication des résultats semestriels
2020Novartis obtient une décision favorable d'un tribunal US sur Gilenya
2020Novartis begrüsst Entscheidung von US-Gericht zu Gilenya (fingolimod)
2020SUN PHARMACEUTICAL INDUSTRIES LTD. : Veröffentlichung des Jahresergebnisses
More news
Analyst Recommendations on SUN PHARMACEUTICAL INDUSTRIES LTD.
More recommendations
Chart SUN PHARMACEUTICAL INDUSTRIES LTD.
Duration : Period :
Sun Pharmaceutical Industries Ltd. Technical Analysis Chart | SUNPHARMA | INE044A01036 | MarketScreener
Technical analysis trends SUN PHARMACEUTICAL INDUSTRIES LTD.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 31
Average target price 607,23 INR
Last Close Price 575,20 INR
Spread / Highest target 33,9%
Spread / Average Target 5,57%
Spread / Lowest Target -27,0%
EPS Revisions
Managers and Directors
NameTitle
Dilip Shantilal Shanghvi Managing Director & Executive Director
Israel Makov Non-Executive Chairman
C. S. Muralidharan Chief Financial Officer
Atanu Roy SVP & Chief Information Officer
Sudhir Vrundavandas Valia Non-Independent Non-Executive Director
Sector and Competitors